Intraperitoneal Polypropylene Light Weight Wide Pore Soft Mesh Repair for Complex Ventral Hernia.
1 other identifier
interventional
59
1 country
1
Brief Summary
Complex ventral hernia is a challenging problem well known to be associated with occurrence of serious complications. The major problems encountered in such cases Include: loss of domain with subsequent increase of intra-abdominal pressure after repair, the huge musculo-fascial defect and skin scarring with possible skin viability problem resulting from the dissection of skin flaps. There is no unified accepted evidence-based approach for its repair and is attended with a high recurrence rate that may reach up to 67%. In a previous study using the ADMIR technique of intraperitoneal repair and after a long-term follow-up the investigator was able to reduce the recurrence rate to 4% after an average follow up period of 142 months. In the current study the investigator will use the same technique of intraperitoneal mesh repair comparing the polypropylene light weight, wide pore, soft mesh with a double mesh using the same polypropylene mesh and a vicryl mesh as a protective layer against the bowel. If it is proven as effective as the mesh with protective layer and with no increased risk of morbidity, this will result in marked reduction of the cost of treatment by nearly 90 % and will abolish the waiting list of patients as the polypropylene mesh is readily available.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2019
CompletedFirst Posted
Study publicly available on registry
June 21, 2019
CompletedStudy Start
First participant enrolled
July 12, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedFebruary 15, 2024
February 1, 2024
4.1 years
June 20, 2019
February 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The development of persistent abdominal pain (VAS), intestinal obstruction or abdominal wall sinus or fistula formation.
Manifestations of intestinal obstruction in the form of abdominal pain (VAS), abdominal distention, vomiting and absolute constipation
one year
Secondary Outcomes (1)
Hernia recurrence.
three years
Study Arms (2)
study arm
ACTIVE COMPARATORIn this arm a light weight, wide pore, soft polypropylene mesh will be used for intraperitoneal hernia repair
control
ACTIVE COMPARATORin this arm a double mesh (vicryl + polypropylene mesh) will be used for intraperitoneal hernia repair.
Interventions
The mesh will be inserted intraperitoneally for complex ventral hernia repair and fixed according the previously described ADMIR technique.
Eligibility Criteria
You may qualify if:
- Adult patients between 18 and 65 years of age, ASA physical status I - III with complex ventral hernia (defect width above 10 cm, loss of domain above 20 %, recurrent hernia and/or associated with fistula or abdominal wall sinuses).
You may not qualify if:
- Age below 18 and above 65 years. The maximum age limit would be 65 years because in our previous studies morbidity was higher in older age group (36, 37).
- Body mass index greater than 45 kg/m2 or weight above 100 kg.
- Pregnancy.
- Associated non treated abdominal malignancy.
- Unstable coronary artery disease, congestive heart failure.
- Significant renal or hepatic impairment;
- Severe bronchopulmonary disease, including chronic obstructive pulmonary disease and obstructive sleep apnea.
- Diabetics with Hb A1c above 7.5.
- Subjects with loss of domain above 20 % who didn't respond to pre-operative progressive pneumoperitoneum.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University Hospitals
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raafat Y Afifi, MD
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The patient will be blinded to the study group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor of General Surgery - primary investigator
Study Record Dates
First Submitted
June 20, 2019
First Posted
June 21, 2019
Study Start
July 12, 2019
Primary Completion
July 31, 2023
Study Completion
July 31, 2023
Last Updated
February 15, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- one year
- Access Criteria
- email contact
Data can be shared at the end of the study.